Avicanna applies to patent a novel cannabinoid drug for severe epilepsy symptoms

Mugglehead
By Natalia Buendia CalvilloOct 20, 2022, 7:10 pm175 pts
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) has sent an application to patent a cannabinoid medicine aimed to treat severe symptoms of epilepsy such as sudden death and epilepsy. On Thursday, the cannabinoid biopharmaceutical company announced the patent application “Methods for reducing or…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Golden Bear Awards: California’s 2025 Best Cannabis Flower, Products Announced 76

USDA Database Describes Marijuana As ‘Medicinal’ Even As Federal Government Keeps It In Schedule I 76

Three Ways to Spice Up Your Summer Sesh 71

Last call at the hemp THC beverage bar in St. Louis? 71

Florida marijuana patients can lose access under new state law 68

How to Be Your Own Cannabis Sommelier 66

'The Studio' Racks Up 23 Emmy Nom for Seth Rogen, Bryan Cranston, Zoë Kravitz, Dave Franco and More 65

Omaha Tribe of Nebraska Passes Adult-Use and Medical Cannabis Legalization 62

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.